Department of Obstetrics and Gynecology, University of Colorado Denver School of Medicine, 12631 East 17th Avenue, Aurora, CO 80045, USA.
BJOG. 2010 Mar;117(4):456-62. doi: 10.1111/j.1471-0528.2009.02473.x. Epub 2010 Jan 14.
To determine the interrelationships during early pregnancy of complement-activation fragments Bb, C3a and sC5b-9, and angiogenesis-related factors placental growth factor (PiGF), soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), and their associations with pre-eclampsia.
Prospective cohort study.
Denver complement study (June 2005-June 2008).
A total of 668 pregnant women with singleton gestations, recruited between 10 and 15 weeks of gestation.
Using univariable and multivariable logistic regression analysis, concentrations of complement-activation fragments and angiogenesis-related factors were compared between 10 and 15 weeks of gestation in women who subsequently did or did not develop pre-eclampsia. Interrelationships between these variables were tested using the non-parametric Spearman rank correlation coefficient.
Pre-eclampsia. The association of complement-activation fragments and angiogenesis-related factors with obesity was also examined.
The mean (+/-SD) levels of complement Bb in early pregnancy among women who did and did not develop pre-eclampsia were 0.84 (+/-0.26) microg/ml and 0.69 (+/-0.2) microg/ml, respectively (P = 0.001). Concentrations of PiGF were significantly (P = 0.01) lower (31 +/- 12 pg/ml) in early pregnancy in the pre-eclamptic group of women, as compared with the normotensive group (39 +/- 32 pg/ml). The adjusted odds ratio (AOR) of Bb and PiGF were 2.1 (CI = 1.4-3.1, P < 0.0003) and 0.2 (CI = 0.07-0.7, P = 0.01), respectively. There was no significant difference in the levels of C3a, sC5b-9, sFlt-1 and sEng in early pregnancy among women who developed pre-eclampsia, compared with women who remained normotensive during pregnancy. Higher levels of Bb (P = 0.0001) and C3a (P = 0.03), and lower levels of sFlt-1 (P = 0.0002) and sEng (P = 0.0001) were found among women with obesity, compared with non-obese controls. No meaningful relationships were found between the complement-activation fragments and the angiogenesis-related factors.
In this cohort during early pregnancy, increased concentrations of complement-activation factor Bb and lower concentrations of PiGF were associated with the development of pre-eclampsia later in pregnancy.
确定补体激活片段 Bb、C3a 和 sC5b-9 以及血管生成相关因子胎盘生长因子(PiGF)、可溶性 fms 样酪氨酸激酶-1(sFlt-1)和可溶性内皮糖蛋白(sEng)在妊娠早期的相互关系,及其与子痫前期的关系。
前瞻性队列研究。
丹佛补体研究(2005 年 6 月至 2008 年 6 月)。
共纳入 668 名单胎妊娠孕妇,招募于妊娠 10-15 周。
采用单变量和多变量逻辑回归分析,比较了随后发生或未发生子痫前期的孕妇在妊娠 10-15 周时补体激活片段和血管生成相关因子的浓度。使用非参数 Spearman 秩相关系数检验这些变量之间的相互关系。
子痫前期。还检查了补体激活片段和血管生成相关因子与肥胖的关系。
子痫前期组孕妇妊娠早期补体 Bb 的平均(+/-SD)水平分别为 0.84(+/-0.26)μg/ml 和 0.69(+/-0.2)μg/ml(P=0.001)。与正常血压组相比,子痫前期组孕妇妊娠早期 PiGF 浓度明显(P=0.01)较低(31+/-12 pg/ml),为 39+/-32 pg/ml。Bb 和 PiGF 的调整比值比(AOR)分别为 2.1(CI=1.4-3.1,P<0.0003)和 0.2(CI=0.07-0.7,P=0.01)。与妊娠期间保持正常血压的孕妇相比,子痫前期孕妇妊娠早期 C3a、sC5b-9、sFlt-1 和 sEng 水平无显著差异。肥胖组孕妇补体 Bb(P=0.0001)和 C3a(P=0.03)水平较高,sFlt-1(P=0.0002)和 sEng(P=0.0001)水平较低,与非肥胖对照组相比。在补体激活片段和血管生成相关因子之间未发现有意义的关系。
在本队列妊娠早期,补体激活因子 Bb 浓度升高和 PiGF 浓度降低与妊娠晚期子痫前期的发生有关。